Topics

Malignancy Ratio and Number Needed to Biopsy: Quality Measures.

08:00 EDT 18th March 2020 | BioPortfolio

Summary of "Malignancy Ratio and Number Needed to Biopsy: Quality Measures."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Journal of the American Academy of Dermatology
ISSN: 1097-6787
Pages:

Links

DeepDyve research library

PubMed Articles [24402 Associated PubMed Articles listed on BioPortfolio]

Minimum Number of MRI Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective Lesion-Based Analyses of Patients Treated with Radical Prostatectomy.

To analyze the number of mpMRI targeted biopsy (TBx) cores per lesion needed for PCa detection in patients treated with radical prostatectomy (RP).

Improving Quality Measurement: Design Principles for Quality Measures.

The use of quality measures to adjust health care payments and to rank providers is growing rapidly, but there are many problems with the quality measures that are currently being used. This article d...

Number, frequency and time interval of examinations under anesthesia in bilateral retinoblastoma.

Current practice in retinoblastoma (Rb) has transformed this malignancy into a curable disease. More attention should therefore be given to quality of life considerations, including measures related t...

Stereotactic 9-gauge vacuum-assisted breast biopsy, how many specimens are needed?

To determine the minimum number of stereotactic 9-gauge vacuum-assisted biopsy specimens required to establish a final histopathological biopsy diagnosis of mammographically suspicious breast lesions.

How many cores should be obtained during saturation biopsy in the era of multiparametric magnetic resonance? Experience in 875 patients submitted to repeat prostate biopsy.

To evaluate the number of needle cores combined with multiparametric magnetic resonance imaging (mpMRI) findings needed to diagnose all clinically significant cases of prostate cancer (csPCa) in men s...

Clinical Trials [14430 Associated Clinical Trials listed on BioPortfolio]

The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions

Prostate cancer is a common disease in men. In prostate 35% of biopsies, usually done due to increased PSA levels or clinical suspicion, are false negative, despite malignancy. Multi-para...

Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

The investigators assume that progression-free survival mean time for patients treated with vinorelbine will be 3 months, and for patients treated with gemcitabine plus vinorelbine will be...

GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response

The main outcome measures are the number of dominant follicles (≥13 mm) on the day of hCG trigger and the number of mature (MII) oocytes collected after conventional versus delayed-start...

Biopsy Incisional With Trepan in Periocular Lesions

The purpose of this study was to identify accuracy rates of 2mm punch biopsy technique in diagnosing periocular malignancy.

New Biopsy Needle - Evaluation of Prostate Biopsy Quality

Patient blinded randomized prospective trial evaluating prostate biopsy quality of a novel biopsy needle.

Medical and Biotech [MESH] Definitions

The application of industrial management practice to systematically maintain and improve organization-wide performance. Effectiveness and success are determined and assessed by quantitative quality measures.

Norms, criteria, standards, and other direct qualitative and quantitative measures used in determining the quality of health care.

The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.

The ratio of the number of conceptions (CONCEPTION) including LIVE BIRTH; STILLBIRTH; and fetal losses, to the mean number of females of reproductive age in a population during a set time period.

The number of males per 100 females.

Quick Search


DeepDyve research library

Searches Linking to this Article